Bacteroides fragilis - Stimulated interleukin-10 contains expanding disease

Journal of Infectious Diseases

Volumn 204, Issue 3, 2011, Pages 363-371

  Cohen Poradosu, Ronit ^a,b   McLoughlin, Rachel M ^a,c   Lee, Jerry C ^a   Kasper, Dennis L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 10; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BACTEROIDES FRAGILIS; BACTEROIDES INFECTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; HOST PATHOGEN INTERACTION; MACROPHAGE ACTIVATION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; WILD TYPE;

ANIMALS; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; DISEASE PROGRESSION; INTERLEUKIN-10; INTERLEUKIN-17; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MYELOID DIFFERENTIATION FACTOR 88; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960122396     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir277     Document Type: Article

References (46)

1. Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev 2007; 20:593-621. (Pubitemid 47623770)
2. Xu J, Gordon JI. Honor thy symbionts. Proc Natl Acad Sci U S A 2003; 100:10452-9. (Pubitemid 37071899)
3. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001; 291:881-4. (Pubitemid 32120760)
4. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010; 107:12204-9.
5. Ruiz-Perez B, Chung DR, Sharpe AH, et al. Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proc Natl Acad Sci U S A 2005; 102:16753-8. (Pubitemid 41688849)
6. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453:620-5. (Pubitemid 351769307)
7. Bartlett JG, Onderdonk AB, Louie T, Kasper DL, Gorbach SL. A review. Lessons from an animal model of intra-abdominal sepsis. Arch Surg 1978; 113:853-7.
8. Polk BF, Kasper DL. Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med 1977; 86:569-71. (Pubitemid 8091107)
9. Krinos CM, Coyne MJ, Weinacht KG, Tzianabos AO, Kasper DL, Comstock LE. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 2001; 414:555-8. (Pubitemid 33131539)
10. Kuwahara T, Yamashita A, Hirakawa H, et al. Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc Natl Acad Sci U S A 2004; 101:14919-24. (Pubitemid 39410775)
11. Baumann H, Tzianabos AO, Brisson JR, Kasper DL, Jennings HJ. Structural elucidation of two capsular polysaccharides from one strain of Bacteroides fragilis using high-resolution NMR spectroscopy. Biochemistry 1992; 31:4081-9.
12. Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHCII pathway. Cell 2004; 117:677-87. (Pubitemid 38692532)
13. Tzianabos AO, Kasper DL, Onderdonk AB. Structure and function of Bacteroides fragilis capsular polysaccharides: relationship to induction and prevention of abscesses. Clin Infect Dis 1995; 20(Suppl 2):S132-40.
14. Tzianabos AO, Onderdonk AB, Rosner B, Cisneros RL, Kasper DL. Structural features of polysaccharides that induce intra-abdominal abscesses. Science 1993; 262:416-9. (Pubitemid 23353382)
15. Tzianabos AO, Onderdonk AB, Smith RS, Kasper DL. Structurefunction relationships for polysaccharide-induced intra-abdominal abscesses. Infect Immun 1994; 62:3590-3. (Pubitemid 24232156)
16. Tzianabos AO, Kasper DL, Cisneros RL, Smith RS, Onderdonk AB. Polysaccharide-mediated protection against abscess formation in experimental intra-abdominal sepsis. J Clin Invest 1995; 96:2727-31.
17. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008; 180:5771-7.
18. Belkaid Y. Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007; 7:875-88. (Pubitemid 350006238)
19. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765. (Pubitemid 32368050)
20. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
21. de Waal Malefyt R, Haanen J, Spits H, et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-24.
22. Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151:1224-34. (Pubitemid 23219258)
23. Ding L, Shevach EM. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 1992; 148:3133-9.
24. Gu Y, Yang J, Ouyang X, et al. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. Eur J Immunol 2008; 38:1807-13.
25. Wu Y, Wang QH, Zheng L, et al. Plasmodium yoelii: distinct CD4(+)CD25(+) regulatory T cell responses during the early stages of infection in susceptible and resistant mice. Exp Parasitol 2007; 115:301-4. (Pubitemid 44828069)
26. Gazzinelli RT, Wysocka M, Hieny S, et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol 1996; 157:798-805.
27. Londono D, Marques A, Hornung RL, Cadavid D. Relapsing fever borreliosis in interleukin-10-deficient mice. Infect Immun 2008; 76:5508-13.
28. Londono D, Marques A, Hornung RL, Cadavid D. IL-10 helps control pathogen load during high-level bacteremia. J Immunol 2008; 181:2076-83.
29. Coyne MJ, Tzianabos AO, Mallory BC, Carey VJ, Kasper DL, Comstock LE. Polysaccharide biosynthesis locus required for virulence of Bacteroides fragilis. Infect Immun 2001; 69:4342-50. (Pubitemid 32574431)
30. Zaleznik DF, Finberg RW, Shapiro ME, Onderdonk AB, Kasper DL. A soluble suppressor T cell factor protects against experimental intraabdominal abscesses. J Clin Invest 1985; 75:1023-7. (Pubitemid 15115272)
31. Tzianabos AO, Russell PR, Onderdonk AB, et al. IL-2 mediates protection against abscess formation in an experimental model of sepsis. J Immunol 1999; 163:893-7. (Pubitemid 29328099)
32. Shapiro ME, Onderdonk AB, Kasper DL, Finberg RW. Cellular immunity to Bacteroides fragilis capsular polysaccharide. J Exp Med 1982; 155:1188-97. (Pubitemid 12142733)
33. Cannon JG, Tompkins RG, Gelfand JA, et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990; 161:79-84. (Pubitemid 20021861)
34. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-50. (Pubitemid 36056721)
35. Matsuzaki G, Umemura M. Interleukin-17 as an effector molecule of innate and acquired immunity against infections. Microbiol Immunol 2007; 51:1139-47.
36. Marchant A, Alegre ML, Hakim A, et al. Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock. J Clin Immunol 1995; 15:266-73.
37. Reed SG, Brownell CE, Russo DM, Silva JS, Grabstein KH, Morrissey PJ. IL-10 mediates susceptibility to Trypanosoma cruzi infection. J Immunol 1994; 153:3135-40. (Pubitemid 24292538)
38. Demangel C, Bertolino P, Britton WJ. Autocrine IL-10 impairs dendritic cell (DC)-derived immune responses to mycobacterial infection by suppressing DC trafficking to draining lymph nodes and local IL-12 production. Eur J Immunol 2002; 32:994-1002. (Pubitemid 34428814)
39. Lazarus JJ, Meadows MJ, Lintner RE, Wooten RM. IL-10 deficiency promotes increased Borrelia burgdorferi clearance predominantly through enhanced innate immune responses. J Immunol 2006; 177:7076-85. (Pubitemid 44715075)
40. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003; 3:331-41. (Pubitemid 37328685)
41. Benoit M, Desnues B, Mege JL. Macrophage polarization in bacterial infections. J Immunol 2008; 181:3733-9.
42. Wang Q, McLoughlin RM, Cobb BA, et al. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med 2006; 203:2853-63. (Pubitemid 46026163)
43. Tzianabos AO, Kasper DL. Role of T cells in abscess formation. Curr Opin Microbiol 2002; 5:92-6. (Pubitemid 34118164)
44. Nulsen MF, Finlay-Jones JJ, Skinner JM, McDonald PJ. Intra-abdominal abscess formation in mice: quantitative studies on bacteria and abscess-potentiating agents. Br J Exp Pathol 1983; 64:345-53. (Pubitemid 13001121)
45. Finlay-Jones JJ, Kenny PA, Nulsen MF, Spencer LK, Hill NL, McDonald PJ. Pathogenesis of intraabdominal abscess formation: abscess-potentiating agents and inhibition of complement-dependent opsonization of abscess-inducing bacteria. J Infect Dis 1991; 164:1173-9.
46. Avila-Campos MJ, Liu C, Song Y, Rowlinson MC, Finegold SM. Determination of bft gene subtypes in Bacteroides fragilis clinical isolates. J Clin Microbiol 2007; 45:1336-8. (Pubitemid 46626511)